2 ms·
OK, I get the dogma. But reality is more complicated. See https://www.pharmaceutical-journal.com/news-and-analysis/features/why-are-there-so-few-antibiotics-i
by mirimir 9y ago
OK, I get the dogma.
But reality is more complicated.
See https://www.pharmaceutical-journal.com/news-and-analysis/features/why-are-there-so-few-antibiotics-in-the-research-and-development-pipeline/11130209.article https://www.pharmaceutical-journal.com/news-and-analysis/fea...
- darkerside 9y agoYou can call it dogma. I think of it as a fundamental principle of human nature. Balancing creativity and efficiency effectively is quite the trick, and capitalism actually pulls it off. People and companies who take risks are the ones that thrive. Those that don't "fade away". It uses survivorship bias to our advantage. Fading away used to mean dying in the streets. Sometimes it still does, but much more rarely. It's a dearly paid price for the innovation that brought us the world as it is today.